$3.34
0.092.77%
At close: -
$3.34
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
4D Molecular Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FDMT | Benzinga
4D Molecular Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.860
Quarterly Revenue Estimate
$529.67K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$37.00K
Analyze the earnings history of 4D Molecular Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics | -$0.66 | -$0.86 | — | — | $28.00K | $529.67K | — | — | 05/08/2025 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.77 | -$0.83 | -$0.90 | -8.43% | -$17.00K | $2.20M | $1.00K | -99.95% | 02/28/2025 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.24 | -$0.70 | -$0.79 | -12.86% | $20.20K | $560.00K | $3.00K | -99.46% | 11/13/2024 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.77 | -$0.71 | -$0.63 | 11.27% | $239.00K | — | $5.00K | — | 08/08/2024 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.88 | -$0.74 | -$0.66 | 10.81% | $298.00K | $780.00K | $28.00K | -96.41% | 05/09/2024 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.84 | -$0.74 | -$0.77 | -4.05% | $1.25M | $2.06M | -$17.00K | -100.83% | 02/29/2024 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.79 | -$0.54 | -$0.24 | 55.56% | $500.00K | $9.87M | $20.20M | 104.70% | 11/09/2023 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.87 | -$0.81 | -$0.77 | 4.94% | $162.00K | $850.00K | $239.00K | -71.88% | 08/09/2023 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.82 | -$0.90 | -$0.88 | 2.22% | $1.22M | $1.03M | $298.00K | -71.07% | 05/10/2023 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.85 | -$0.79 | -$0.84 | -6.33% | $92.00K | $3.01M | $1.25M | -58.57% | 03/15/2023 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.82 | -$0.91 | -$0.79 | 13.19% | $1.37M | — | $500.00K | — | 11/08/2022 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.28 | -$0.85 | -$0.87 | -2.35% | $14.58M | $860.00K | $162.00K | -81.16% | 08/11/2022 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$0.61 | — | -$0.82 | — | $2.00M | — | $1.22M | — | 05/12/2022 | Get Alert |
| FDMT | 4D Molecular Therapeutics | — | -$0.86 | -$0.85 | 1.16% | — | — | $92.00K | — | 03/28/2022 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$1.51 | -$0.80 | -$0.82 | -2.50% | $7.42M | $170.00K | $1.37M | 703.53% | 11/10/2021 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$2.92 | -$0.68 | -$0.28 | 58.82% | $3.63M | $14.58M | $14.58M | 0.00% | 08/12/2021 | Get Alert |
| FDMT | 4D Molecular Therapeutics | -$2.54 | -$1.17 | -$0.61 | 47.86% | $3.50M | — | $2.00M | — | 05/13/2021 | Get Alert |
4D Molecular Therapeutics (FDMT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $-0.90 | $-0.83 | -8.43 % |
| Q3 | 2024-11-13 | $-0.79 | $-0.70 | -12.9 % |
| Q2 | 2024-08-08 | $-0.63 | $-0.71 | 11.3 % |
| Q1 | 2024-05-09 | $-0.66 | $-0.74 | 10.8 % |
4D Molecular Therapeutics (FDMT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $1.00K | $2.20M | -100.0 % |
| Q3 | 2024-11-13 | $3.00K | $560.00K | -99.5 % |
| Q1 | 2024-05-09 | $28.00K | $780.00K | -96.4 % |
| Q4 | 2024-02-29 | $-17.00K | $2.06M | -100.8 % |
FAQ
When is 4D Molecular Therapeutics (NASDAQ:FDMT) reporting earnings?
4D Molecular Therapeutics (FDMT) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 28, 2025 for Q4.
What were the latest earnings per share (EPS) for 4D Molecular Therapeutics (NASDAQ:FDMT)?
The Actual EPS was $-0.90, which missed the estimate of $-0.83.
What were 4D Molecular Therapeutics’s (NASDAQ:FDMT) revenues?
The Actual Revenue was $1K, which missed the estimate of $2.2M.
Browse earnings estimates, EPS, and revenue on all stocks.
